Shanghai Longwood Biopharmaceuticals Co., Ltd.

This study is testing a new drug called LW231 in people with chronic hepatitis B. The main goals are to check if it's safe, how the body processes it, and if it can lower the amount of virus in the blood. Researchers will test different doses and also see how it works when given …